immortal71/openoncology

Open source precision oncology platform that ranks FDA approved and repurposing drug candidates from a patient's variant profile using OncoKB, AlphaMissense, OpenTargets and ChEMBL evidence. Blinded 50 case oncologist holdout: Hit@3 0.900, zero false positives.